Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules.
作者信息
Velagapudi Sai Pradeep, Seedhouse Steven J, Disney Matthew D
机构信息
Department of Chemistry and Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, The State University of New York, 657 Natural Sciences Complex, Buffalo, NY 14260, USA.
出版信息
Angew Chem Int Ed Engl. 2010 May 17;49(22):3816-8. doi: 10.1002/anie.200907257.
Abstract
摘要
相似文献
1
Structure-activity relationships through sequencing (StARTS) defines optimal and suboptimal RNA motif targets for small molecules.
Angew Chem Int Ed Engl. 2010 May 17;49(22):3816-8. doi: 10.1002/anie.200907257.
2
Defining RNA motif-aminoglycoside interactions via two-dimensional combinatorial screening and structure-activity relationships through sequencing.
Bioorg Med Chem. 2013 Oct 15;21(20):6132-8. doi: 10.1016/j.bmc.2013.04.072. Epub 2013 May 7.
3
Strategies for the design of RNA-binding small molecules.
Future Med Chem. 2010 Jan;2(1):93-119. doi: 10.4155/fmc.09.149.
4
Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside-RNA hairpin loop interactions.
Nucleic Acids Res. 2009 Sep;37(17):5894-907. doi: 10.1093/nar/gkp594. Epub 2009 Sep 2.
5
A microarray-based method to perform nucleic acid selections.
Methods Mol Biol. 2010;669:209-24. doi: 10.1007/978-1-60761-845-4_17.
6
A tale of two targets: differential RNA selectivity of nucleobase-aminoglycoside conjugates.
Chembiochem. 2006 Oct;7(10):1612-21. doi: 10.1002/cbic.200600109.
7
Sensing the impact of environment on small molecule differentiation of RNA sequences.
Chem Commun (Camb). 2017 Dec 14;53(100):13363-13366. doi: 10.1039/c7cc07157d.
8
Docking of aminoglycosides to hydrated and flexible RNA.
J Med Chem. 2006 Feb 9;49(3):1023-33. doi: 10.1021/jm0508437.
9
Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners.
J Am Chem Soc. 2008 Aug 20;130(33):11185-94. doi: 10.1021/ja803234t. Epub 2008 Jul 25.
10
Targeting RNA with small molecules.
Chem Rev. 2008 Apr;108(4):1171-224. doi: 10.1021/cr0681546. Epub 2008 Mar 25.
引用本文的文献
1
Small molecule approaches to targeting RNA.
Nat Rev Chem. 2024 Feb;8(2):120-135. doi: 10.1038/s41570-023-00569-9. Epub 2024 Jan 26.
2
RNA-ligand molecular docking: advances and challenges.
Wiley Interdiscip Rev Comput Mol Sci. 2022 May-Jun;12(3). doi: 10.1002/wcms.1571. Epub 2021 Aug 16.
3
Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery.
ACS Med Chem Lett. 2023 Feb 23;14(3):251-259. doi: 10.1021/acsmedchemlett.3c00020. eCollection 2023 Mar 9.
4
Expanding the DNA-encoded library toolbox: identifying small molecules targeting RNA.
Nucleic Acids Res. 2022 Jul 8;50(12):e67. doi: 10.1093/nar/gkac173.
5
Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications.
Cancers (Basel). 2021 Mar 28;13(7):1555. doi: 10.3390/cancers13071555.
6
Frameworks for targeting RNA with small molecules.
J Biol Chem. 2021 Jan-Jun;296:100191. doi: 10.1074/jbc.REV120.015203. Epub 2020 Dec 20.
7
Targeting RNA structures in diseases with small molecules.
Essays Biochem. 2020 Dec 7;64(6):955-966. doi: 10.1042/EBC20200011.
8
A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified Mice.
Adv Sci (Weinh). 2020 May 28;7(13):1903451. doi: 10.1002/advs.201903451. eCollection 2020 Jul.
9
Synthetic small-molecule RNA ligands: future prospects as therapeutic agents.
Medchemcomm. 2019 Apr 30;10(8):1242-1255. doi: 10.1039/c9md00195f. eCollection 2019 Aug 1.
10
Unveiling the druggable RNA targets and small molecule therapeutics.
Bioorg Med Chem. 2019 May 15;27(10):2149-2165. doi: 10.1016/j.bmc.2019.03.057. Epub 2019 Mar 30.
本文引用的文献
1
Two-dimensional combinatorial screening and the RNA Privileged Space Predictor program efficiently identify aminoglycoside-RNA hairpin loop interactions.
Nucleic Acids Res. 2009 Sep;37(17):5894-907. doi: 10.1093/nar/gkp594. Epub 2009 Sep 2.
2
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.
J Am Chem Soc. 2009 Jul 22;131(28):9767-79. doi: 10.1021/ja9020149.
3
Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2.
ACS Chem Biol. 2009 May 15;4(5):345-55. doi: 10.1021/cb900025w.
4
Myotonic dystrophy: therapeutic strategies for the future.
Neurotherapeutics. 2008 Oct;5(4):592-600. doi: 10.1016/j.nurt.2008.08.001.
5
Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners.
J Am Chem Soc. 2008 Aug 20;130(33):11185-94. doi: 10.1021/ja803234t. Epub 2008 Jul 25.
6
Targeting RNA with small molecules.
Chem Rev. 2008 Apr;108(4):1171-224. doi: 10.1021/cr0681546. Epub 2008 Mar 25.
7
A simple ligation-based method to increase the information density in sequencing reactions used to deconvolute nucleic acid selections.
RNA. 2008 Feb;14(2):390-4. doi: 10.1261/rna.576908. Epub 2007 Dec 7.
8
A small molecule microarray platform to select RNA internal loop-ligand interactions.
ACS Chem Biol. 2007 Nov 20;2(11):745-54. doi: 10.1021/cb700174r. Epub 2007 Nov 2.
9
MicroRNAs as therapeutic targets in human diseases.
Expert Opin Ther Targets. 2007 Aug;11(8):1119-29. doi: 10.1517/14728222.11.8.1119.
10
Riboswitches as antibacterial drug targets.
Nat Biotechnol. 2006 Dec;24(12):1558-64. doi: 10.1038/nbt1268.
Zotero 插件